The role of ELK1 in cancer cell aggressiveness was also validated by another study focusing on Octamer transcription factor 1 (OCT1; also known as POU domain, class 2, transcription factor 1, POU2F1) [187]. This evidence concerns the gene POU2F1 and cancer.